March 31 (Reuters) - Deep Medicine Acquisition Corp
DMAQ.O :
* . AND TRUGOLF, INC. ANNOUNCE THE EXECUTION OF A DEFINITIVE
MERGER AGREEMENT
* BUSINESS COMBINATION WITH DEEP MEDICINE ACQUISITION CORP.
VALUES
TRUGOLF'S AT AN IMPLIED ENTERPRISE VALUE OF $125 MILLION
* CHRISTOPHER JONES, CEO AND CHAIRMAN OF TRUGOLF, AND
EXISTING
MANAGEMENT TEAM WILL LEAD MERGED COMPANY
* DEEP MEDICINE ACQUISITION - PROCEEDS FROM TRANSACTION WILL
ENHANCE TRUGOLF'S PRODUCTION CAPACITY, NEW PRODUCT RESEARCH AND
DEVELOPMENT
* TRANSACTION CONSIDERATION WILL BE PAID IN NEWLY ISSUED
SHARES OF
COMMON STOCK OF DMAQ
* UPON COMPLETION OF TRANSACTION, DMAQ WILL BE RENAMED
"TRUGOLF,
INC." AND WILL BE LISTED ON NASDAQ STOCK MARKET
* DMAQ SHARES OF COMMON STOCK WILL TRADE UNDER TRADING
SYMBOL
"TRUG"
* COMBINED COMPANY IS EXPECTED TO HAVE A TOTAL PRO FORMA
EQUITY
VALUE OF APPROXIMATELY $134.1 MILLION
Source text for Eikon: ID:nGNX4yFJqB
Further company coverage: DMAQ.O
((reuters.briefs@thomsonreuters.com;))